Hearing loss in patients with Morquio A syndrome: A scoping review. [PDF]
Diaz-Ordoñez L +8 more
europepmc +1 more source
Rat models of musculoskeletal lysosomal storage disorders and their role in pre-clinical evaluation of gene therapy approaches. [PDF]
Marcó S, Muñoz S, Bosch F, Jimenez V.
europepmc +1 more source
Real-world treatment with elosulfase alfa in patients with MPS IVA is associated with improved endurance over time. [PDF]
Burton BK +6 more
europepmc +1 more source
A Rare Case of Dyggve-Melchior-Clausen Syndrome: A Case Report. [PDF]
Chavan S +4 more
europepmc +1 more source
Mucopolysaccharidosis type IVA and severe hidradenitis suppurativa: A case series. [PDF]
Fialová J +3 more
europepmc +1 more source
MUSCULOSKELETAL ALTERATIONS OF ORTHOPEDIC INTEREST IN MUCOPOLYSACCHARIDOSES. [PDF]
Matos MA, Lopes PS.
europepmc +1 more source
Mucopolysaccharidoses-What Clinicians Need to Know: A Clinical, Biochemical, and Molecular Overview. [PDF]
Lipiński P +11 more
europepmc +1 more source
Related searches:
Mucopolysaccharidosis type IVA (morquio syndrome): A clinical review
Journal of Inherited Metabolic Disease, 1996SummaryPatients with MPS IV have a clinical disorder quite different from other MPS conditions. The major treatment issue revolves around the prevention of cervical myelopathy, although the other aspects of this multisystem disease should not be forgotten.
H. Northover, R. Cowie, J. Wraith
semanticscholar +3 more sources
Morquio Syndrome: A Rehabilitation Perspective
The Journal of Spinal Cord Medicine, 1996Morquio Syndrome (mucopolysaccharidosis type IV A) is a rare inherited connective tissue disorder characterized by skeletal dysplasia, restrictive pulmonary disease and normal intelligence. Tetraplegia secondary to subluxation of C1 over C2 because of odontoid dysplasia is a common occurrence in these patients but there are limited descriptions ...
M S, Gulati, M A, Agin
openaire +2 more sources

